Back
Day Range
$22.34
$22.98
52-Week Range
$15.47
$27.22
Volume
232,221
50D / 200D Avg
$22.89
/
$21.19
Prev Close
$21.95
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -6.1 | 0.2 |
| P/B | 3.3 | 3.0 |
| ROE % | -58.9 | 3.6 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$44.00
+93.4%
Low: $43.00
High: $45.00
Forward EPS
-$3.76
Est. Revenue
125,000.0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.55
$1.66 – $5.62
|
433.92M | 5 |
| FY2029 |
$0.84
$0.39 – $1.34
|
266.77M | 2 |
| FY2028 |
-$1.47
-$3.61 – $1.91
|
130.96M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | -$0.85 | -$0.78 | +7.8% |
| 2025-11-10 | -$0.78 | -$0.83 | -6.4% |
| 2025-08-11 | -$0.70 | -$0.90 | -28.6% |
| 2025-05-12 | -$0.66 | -$1.90 | -187.9% |
| 2025-03-03 | -$0.78 | -$0.60 | +23.1% |
| 2024-11-14 | -$0.82 | -$0.61 | +25.6% |
| 2024-08-14 | -$0.65 | -$0.65 | 0.0% |
| 2024-05-08 | -$0.84 | -$0.70 | +16.7% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -160.59M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-58.88%
ROIC-43.34%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio12.83
Interest Coverage0.00
Valuation
P/E Ratio
-6.05
Forward P/EN/A
P/B Ratio3.27
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -166.31M |
| ROE | -58.88% | ROA | -49.92% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -160.59M |
| ROIC | -43.34% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 12.83 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6.05 | Forward P/E | N/A |
| P/B Ratio | 3.27 | P/S Ratio | N/A |
| PEG Ratio | -0.07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 8044.70 | Fwd Earnings Yield | N/A |
| FCF Yield | -15.97% | ||
| Market Cap | 1.01B | Enterprise Value | 960.06M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -166.31M | -80.49M | -69.33M | -36.91M | -51.61M |
| EPS (Diluted) | -4.32 | -2.56 | -2.17 | -1.10 | -40.44 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -177.53M | -94.31M | -74.59M | -36.91M | -8.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 333.17M | 274.94M | 163.10M | 182.83M | 43.04M |
| Total Liabilities | 25.95M | 17.29M | 11.80M | 8.37M | 1.82M |
| Shareholders' Equity | 307.22M | 257.65M | 151.30M | 174.46M | 41.22M |
| Total Debt | 14,000.0 | 176,000.0 | 317,000.0 | 139,000.0 | 0.0 |
| Cash & Equivalents | 45.54M | 74.29M | 150.39M | 163.37M | 37.28M |
| Current Assets | 332.90M | 226.98M | 159.97M | 182.62M | 42.95M |
| Current Liabilities | 25.95M | 17.27M | 11.62M | 8.36M | 1.82M |